Document:

RELEASE AGREEMENT

     This Release  Agreement  (this  "Agreement") is effective as of November 6,
2000 between Joseph S. Compofelice ("Compofelice") and CompX International Inc.,
a Delaware  corporation  (the "CompX").  In consideration of the mutual promises
herein contained, and of other good and valuable consideration,  the receipt and
sufficiency of which are hereby acknowledged, the parties agree as follows.

     Section 1. Resignation of All Position.  If Compofelice has not provided an
earlier  resignation date in writing to CompX or any of its affiliated  entities
(collectively,   the  "Affiliated  Entities"),   Compofelice   acknowledges  his
resignation from all positions with the Affiliated  Entities effective as of the
date of this Agreement,  and agrees to provide such letters as may be reasonably
requested  of him to  evidence  his  resignation  from  all  positions  with the
Affiliated Entities.

    Section 2.  General Release

          (a) Compofelice hereby releases,  acquits,  and forever discharges any
     and all claims and demands of whatever kind or character  that  Compofelice
     or his family  members may now have or assert or  hereafter  have or assert
     against  the  Affiliated  Entities  or any of  their  officers,  directors,
     employees,  agents  or  insurers  for  any  liability,  whether  vicarious,
     derivative or direct, whether fixed,  liquidated or contingent,  or whether
     known or unknown, with respect to the period commencing at the beginning of
     time and continuing through the effective date of this Agreement.

          (b) CompX hereby releases, acquits, and forever discharges any and all
     claims and demands of whatever kind or character that CompX may now have or
     assert or hereafter have or assert against  Compofelice  for any liability,
     whether  vicarious,  derivative  or direct,  whether  fixed,  liquidated or
     contingent,  or  whether  known or  unknown,  with  respect  to the  period
     commencing  at the beginning of time and  continuing  through the effective
     date of this Agreement.

     Section 3. Payment.  CompX agrees upon the  execution of this  Agreement to
pay Compofelice  $500,000 in a form reasonably  satisfactory to Compofelice less
applicable withholding for tax purposes.

     Section 4.  Counterparts.  This  Agreement  may be  executed by the parties
hereto in any number of counterparts, each of which shall be deemed an original,
but all of which shall constitute one and the same agreement.

     Section 5. Jurisdiction.  It is understood and agreed that the construction
and  interpretation  of this Agreement shall at all times and in all respects be
governed by and construed in accordance with the laws of the state of Texas. Any
action  brought  under  this  Agreement  or  otherwise  brought  by CompX or its
affiliates  against  Compofelice  shall be brought  in a court  seated in Dallas
County,  Texas and the parties  waive any right to object to such location as an
improper venue for such claim.

     Section 6. Complete Agreement. This Agreement contains the entire Agreement
and the  understanding  by and between the parties  with  respect to the subject
hereof and supersedes any previously  existing  agreements  between the parties.
This  Agreement  may not be  modified  or  amended in any  respect  except by an
instrument in writing signed by both of the parties hereto.

     IN  WITHESS  WHEREOF,  effective  as of the date  first  set  forth  above,
Compofelice  has executed this  Agreement and CompX has caused this Agreement to
be executed on its behalf by its duly authorized officer.

                                     CompX International Inc.

/s/ Joseph S. Compofelice            By:  /s/ Glenn R. Simmons
------------------------------       -------------------------------------------
Joseph S. Compofelice                Glenn R. Simmons, Chairman of the Board and
                                     Chief Executive OfficerBOND AMENDMENT AGREEMENT

     THIS BOND AMENDMENT AGREEMENT (the "Agreement") is made effective as of the
5th day of January, 2001, by and among Derma Sciences, Inc., a Pennsylvania
corporation with offices located at 214 Carnegie Center, Suite 100, Princeton,
New Jersey ("Company"), and Galen Partners III, L.P., a Delaware limited
partnership with offices at 610 Fifth Avenue, New York, New York 10020, Galen
Partners International III, L.P., a Delaware limited partnership with offices at
610 Fifth Avenue, New York, New York 10020 and Galen Employee Fund III, L.P., a
Delaware limited partnership with offices at 610 Fifth Avenue, New York, New
York 10020 (these latter individually, a "Bondholder" and collectively, the
"Bondholders").

     IN CONSIDERATION of the mutual promises and covenants herein contained, the
Company and each of the Bondholders agree as follows:

     1. APPLICABILITY. This Agreement applies to, and modifies, those certain
convertible bonds of the Company, including the Terms and Conditions thereof,
(collectively, the "Bonds") hereinbelow described:

  SERIES C CONVERTIBLE BONDS ORIGINALLY DUE AUGUST 15, 2000 ("SERIES C BONDS")

Bondholder                                Certificate No.    Principal Amount
                                          ---------------    ----------------
Galen Partners III, L.P.                        CB-6               $22,839.00
Galen Partners International III, L.P.          CB-7                $2,067.00
Galen Employee Fund III, L.P.                   CB-8                   $94.00

 SERIES D CONVERTIBLE BONDS ORIGINALLY DUE DECEMBER 31, 2000 ("SERIES D BONDS")

Bondholder                                Certificate No.    Principal Amount
                                          ---------------    ----------------
Galen Partners III, L.P.                        CBB-1             $411,104.00
Galen Partners International III, L.P.          CBB-2              $37,212.00
Galen Employee Fund III, L.P.                   CBB-3               $1,684.00

                                       1

<PAGE>

     2. POSTPONEMENT OF STATED MATURITY. The "Stated Maturity" as this term is
defined in paragraph 1, page 1, of the bond instrument, as amended, of each of
the Bonds, is hereby amended to read, and each of the Bonds shall mature and be
payable on, January 7, 2002.

     3. NOTICE OF PREPAYMENT. The penultimate sentence in paragraph 2, page 1,
of the bond instrument, as amended, of each of the Bonds, is hereby amended to
read in full as follows: "Upon not less than ten (10) business days prior
written notice to each Bondholder, all or any part of the unpaid principal
balance or accrued but unpaid interest may be prepaid by the Company at any
time, and from time to time, without premium or penalty."

     4. ACCRUAL OF INTEREST. The provisions of paragraph 2, page 1, of the bond
instrument, as amended, of each of the Bonds notwithstanding, interest on the
Bonds shall accrue and be payable upon the Stated Maturity thereof. In addition
to the foregoing, the Company hereby acknowledges that accrued but unpaid
interest in the aggregate amount of $32,709.59 was due and owing at the time of
the conversion by the Bondholders of an aggregate of $375,000 original principal
amount of the $400,000 original principal amount Series C Convertible Bonds on
July 26, 2000 (the "Conversion Date"), and that this amount, together with
interest accruing thereon commencing the Conversion Date at the "Prime Rate" as
specified in the bond instrument, as amended, of each of the Series C
Convertible Bonds, shall be payable upon the Stated Maturity of the remaining
Series C Convertible Bonds together with regular accrued interest on such
remaining Series C Convertible Bonds.

     5. CONVERSION. Each of paragraph 2, page 2, of the bond instrument, as
amended, of each of the Bonds, and the last sentence of paragraph 1(d) of the
Terms and Conditions of the Bonds, is hereby amended to provide that a
Bondholder may, at its option, convert all or any

                                       2

<PAGE>

portion of the unpaid principal sum and accrued unpaid interest of the Bonds
into Units in accordance with the Terms and Conditions of the Bonds.

     6. UNIT PURCHASE PRICE. The Unit Purchase Price set forth in paragraph 2(c)
of the Terms and Conditions of each of the Bonds is amended from "$1.10" (Series
C Bonds) and from "$1.0125" (Series D Bonds) to "$0.50," respectively.

     7. WARRANT COVERAGE AND EXERCISE PRICE. The ratio of warrants to preferred
stock comprising the Units specified in paragraph 1(d) of the Terms and
Conditions of the Bonds is amended from "one share of Series C Convertible
Preferred Stock and one Warrant" (Series C Bonds) and from "one share of Series
D Convertible Preferred Stock and one Warrant" (Series D Bonds) to "one share of
Series C Convertible Preferred Stock and one and one tenth Warrants" (Series C
Bonds) and "one share of Series D Preferred Stock and one and one tenth
Warrants" (Series D Bonds). The exercise price of the Warrants referred to in
this paragraph 7 is amended from "$1.10" (Series C Bonds) and from "$1.01"
(Series D Bonds) to "$0.57," respectively.

     8. GRANT OF COMMON STOCK. The Company will issue a total of Fifty Seven
Thousand (57,000) shares of its common stock (the "Common Stock") to the
Bondholders, and in the amounts, set forth below:

       Bondholder                                        Number of Shares
       ----------                                        ----------------
       Galen Partners III, L.P.                                51,764
       Galen Partners International III, L.P.                   5,009
       Galen Employee Fund III, L.P.                              227

     Upon the issuance thereof, such shares of Common Stock will be fully-paid
and nonassessable, and free and clear of any liens, claims or encumbrances.
Within ninety (90) days of the date hereof, the Company will file with the
Securities and Exchange Commission a

                                       3

<PAGE>

registration statement covering the sale of the Common Stock and will use its
best efforts to cause same to be declared effective as promptly as practicable.

     9. REAFFIRMATION. Except as otherwise modified herein, the Bonds remain
enforceable obligations of the Company in accordance with their original tenor,
terms and conditions.

                            [Signatures on next page]

                                       4

<PAGE>

     IN WITNESS WHEREOF, the Bondholders and the Company have caused this
Agreement to be executed by their duly authorized representatives the day and
year first above written.

                              GALEN PARTNERS III, L.P.

                              By:   Claudius, L.L.C.
                                    Its General Partner

                              By:  /s/Bruce F. Wessen
                                  --------------------------------------------
                                    Bruce F. Wesson
                                    Senior Managing Member

                              GALEN PARTNERS INTERNATIONAL III, L.P.

                              By:   Claudius, L.L.C.
                                    Its General Partner

                              By:  /s/Bruce F. Wessen
                                 ---------------------------------------------
                                    Bruce F. Wesson
                                    Senior Managing Member

                              GALEN EMPLOYEE FUND III, L.P.

                              By:   Wesson Enterprises, Inc.
                                    Its General Partner

                              By:  /s/Bruce F. Wessen
                                 ---------------------------------------------
                                    Bruce F. Wesson
                                    President

                              DERMA SCIENCES, INC.:

                              By:  /s/John E. Yetter
                                 ---------------------------------------------
                                    John E. Yetter, CPA
                                    Vice President and Chief Financial Officer

                                       5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00021-of-00352.parquet"}]]